#cardiovascular

Researchers analyzed autopsies among people with HIV who died in New York City since 1984.

Study finds the two types of stroke, ischemic and hemorrhagic, have different risk factors.

Researchers compared health outcomes among people with HIV, including those with and without hepatitis C.

Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.

Researchers reached this conclusion after reviewing data on more than 30,000 people.

A meta-analysis has helped clear up conflicting previous evidence regarding this association.

A study of veterans also found, as other studies have, that treating the virus helps mitigate the risk of cardiovascular disease.

A European study of nearly 19,000 people with HIV also found that curing hep C was not associated with heart disease or non-AIDS cancer.

Direct-acting antivirals lower the risk of cardiovascular disease to a greater extent than interferon-based regimens.

A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.

Direct-acting antivirals lower this risk to a greater extent than interferon-based regimens.

A recent analysis of two studies of AbbVie’s hepatitis C regimen showed good results in this population.

This is according to an analysis of nearly 5,000 Italians recently treated for the virus.

Conditions such as autoimmune disorders, insulin resistance and cardiovascular disease tend to have a better outlook.

Conditions such as autoimmune disorders, insulin resistance and cardiovascular disease tend to have a better outlook.

This is according to an analysis of nearly 5,000 Italians recently treated for the virus.